JBM (Healthcare) Limited provided group earnings guidance for the six months ended 30 September 2023. For the period, the Group is expected that the consolidated profit attributable to Shareholders reaches the level of approximately HKD 62 million which would represent around threefold compared with the same period of last year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.93 HKD | -1.06% | -3.12% | -11.43% |
May. 03 | JBM to See 120% Increase in Fiscal 2024 Profit | MT |
May. 03 | Jbm Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended March 31, 2024 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.43% | 98.47M | |
+37.29% | 6.02B | |
-21.28% | 4.19B | |
+4.52% | 3.25B | |
-18.16% | 2.87B | |
-7.70% | 2.37B | |
+41.50% | 1.89B | |
-4.05% | 1.58B | |
-15.56% | 1.54B | |
-14.62% | 1.5B |
- Stock Market
- Equities
- 2161 Stock
- News JBM (Healthcare) Limited
- JBM Limited Provides Group Earnings Guidance for the Six Months Ended 30 September 2023